Description

• Initial treatment of advanced ovarian carcinoma of epithelial origin in established combinations with other approved chemotherapeutic agents
• For the palliative treatment of ovarian carcinoma of epithelial origin refractory to standard chemotherapy with or without cisplatin
• For the treatment of small cell lung carcinoma